신생아용 인큐베이터 및 워머 시장 규모, 점유율, 동향 분석 보고서 : 유형별, 지역별, 부문별 예측(2026-2033년)

Infant Incubators And Warmers Market Summary

The global infant incubators and warmers market size was estimated at USD 1.10 billion in 2025 and is expected to reach USD 1.95 billion by 2033, growing at a CAGR of 7.59% 2026 to 2033. The demand in the market is expected to reach USD 1.95 billion in 2033.

The significant number of newborn deaths and preterm births, along with the availability of financial assistance for equipment research & procurement, is expected to boost market growth. Moreover, product innovations by manufacturers are increasing treatment efficiency and affordability, which is expected to reduce treatment costs. Furthermore, community-led initiatives have played a crucial role in enhancing infant care services and expanding access to essential medical equipment. In December 2023, the fundraising efforts led by a former Mayor of Thurrock made a meaningful contribution to improving newborn care capacity at Basildon Hospital. During this initiative, Cllr Susan Little, who was serving as Mayor of Thurrock at the time, together with former Mayor Cllr James Halden, formally presented Basildon's Neonatal Intensive Care Unit (NICU) with funds that enabled the purchase of a USD 48,097.7 portable incubator. This advanced equipment was intended to support the safe and efficient transport of premature and critically ill infants within the unit.

The children born at less than 37 weeks of gestational age are preterm infants, and children born with less than 2.5 kg are Low Birth Weight (LBW) infants. The number of preterm births is constantly rising, which is increasing the demand for care devices. According to the World Health Organization, approximately 13.4 million babies were born preterm in 2020, accounting for nearly one in ten live births. The burden of preterm births is particularly high in low- and middle-income countries, where access to advanced newborn care is often limited. In addition, Low birth weight remains another critical concern in neonatal health. The World Health Organization's 2024 report states that 15-20% of babies globally are born with low birth weight, which means over 20 million infants each year weigh less than 2,500 grams. This condition is strongly associated with increased risks of neonatal morbidity and mortality.

Government and NGO interventions continue to play a crucial role in shaping the growth of the infant incubators and warmers market. Over the past several years, national health programs and international aid efforts have significantly expanded infant care capacity, particularly in regions burdened with high rates of preterm and low birth-weight births. In India, for instance, the government has steadily scaled up its network of Special Newborn Care Units (SNCUs). According to a UNICEF report published in 2024, the number of Special Newborn Care Units (SNCUs) in India increased from 712 in 2017 to 1,054 units by 2024, reflecting a determined effort to enhance newborn survival rates.

Furthermore, NGOs have contributed significantly to bridging gaps in neonatal healthcare infrastructure, particularly in low-resource settings. Organizations such as UNICEF, PATH, and Save the Children have collaborated with governments to provide critical equipment, training, and technical support. For instance, UNICEF has been actively involved in supporting the development and piloting of affordable and portable thermal care technologies designed to help maintain body temperature in premature and low-birth-weight infants, particularly in low-resource and emergency settings. Such efforts have enabled smaller healthcare facilities, especially in rural regions, to maintain the thermal regulation crucial for the survival of preterm and low-birth-weight infants.

In addition, initiatives such as India's Newborn Action Plan (INAP) have prioritized reducing newborn mortality by focusing on expanding facility-based newborn care and improving quality standards across healthcare systems. Similarly, the Baby-Friendly Hospital Initiative (BFHI), supported by WHO and UNICEF, has encouraged hospitals globally to adopt evidence-based practices that enhance maternal and newborn care, including early initiation of breastfeeding and maintaining thermal protection for newborns, which in turn drives demand for advanced infant equipment such as incubators and warmers.

Rising technological advancements are boosting the growth of the market. Over recent years, manufacturers have focused on developing devices with enhanced precision, safety, and usability to support the complex requirements of infant care. Among emerging innovations, infant phototherapy incubators are gaining prominence by combining high-intensity phototherapy for treating newborn jaundice with precise thermal and humidity regulation in a single, integrated system. These devices enable clinicians to manage hyperbilirubinemia effectively and maintain a controlled environment, minimizing the need to transfer delicate infants between separate units.

Manufacturers are responding to this trend by developing compact incubators and warmers that feature simplified controls, battery-powered operation, and remote monitoring capabilities. These devices are designed to be intuitive for caregivers and ensure clinical standards of care. The shift toward home-based newborn care also aligns with broader healthcare goals of decentralization and personalized medicine, creating a favorable market landscape for companies offering technologically advanced and affordable solutions.

For instance, mOm incubators aims to transform neonatal care by ensuring every newborn receives the best possible start through innovative, flexible incubation technology. In the UK, around 600,000 babies are born annually, and up to 16% require NICU care, often resulting in stressful separation from parents and added pressure on the healthcare system. The mOm Essential Incubator addresses this challenge by offering a portable, first-of-its-kind neonatal incubator that can be used anywhere in a hospital, enabling babies born from 30 weeks of gestation onward to stay closer to their families. This covers nearly 90% of infants who typically need NICU support. By supporting Family Integrated Care, the device promotes parent-infant bonding, reduces emotional strain, and helps stabilize infants earlier, lowering the risk of complications such as respiratory distress and hypoglycemia.

Moreover, as healthcare providers and policymakers increasingly focus on community-based care models, the market for infant incubators and warmers is poised to benefit from this evolving care paradigm. This shift presents new growth opportunities in both developed and emerging regions.

In addition, the FDA in January 2025 confirmed that all newly manufactured neonatal incubators in the U.S. are safe for immediate clinical use, resolving earlier concerns about harmful airborne chemicals inside the devices. After first warning healthcare providers in February 2023 about potential exposure to volatile chemicals such as formaldehyde and cyclohexanone, the agency worked closely with manufacturers-reviewing test data and assessing possible health risks for vulnerable newborns. The evaluation found no dangerous chemical levels, meaning incubators no longer require a week-long pre-use ventilation period. GE HealthCare also adopted additional steps to reduce formaldehyde levels in its incubators before distribution.

Global Infant Incubators And Warmers Market Trends Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global infant incubators and warmers market report based on type and regions.

• Type Outlook (Revenue, USD Million, 2021 - 2033)
• Infant Warmers
  • Value
  • Performance
  • Premium
• Incubators
  • Value
  • Performance
  • Premium
• Convertible Warmers & Incubators
  • Value
  • Performance
  • Premium
• Regional Outlook (Revenue, USD Million, 2021 - 2033)
• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Denmark
  • Sweden
  • Norway
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Thailand
• Latin America
  • Brazil
  • Argentina
• Middle East and Africa (MEA)
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

• 1.1 Market Segmentation & Scope
• 1.2 Segment Definitions
  • 1.2.1 Type
• 1.3 Research Methodology
  • 1.3.1 Commodity flow analysis
  • 1.3.2 Information procurement
    • 1.3.2.1 Purchased database
    • 1.3.2.2 GVR'S internal database
    • 1.3.2.3 Primary research
• 1.4 Information or Data Analysis
  • 1.4.1 Data analysis models
• 1.5 Market Formulation & Validation
• 1.6 List of Secondary Sources
• 1.7 List of Abbreviations
• 1.8 Objectives

Chapter 2. Executive Summary

• 2.1 Market Snapshot
• 2.2 Market Segmentation (Type Outlook)
• 2.3 Competitive Landscape

Chapter 3. Market Variables, Trends & Scope

• 3.1 Market Lineage Outlook
• 3.2 Market Dynamics
  • 3.2.1 Market Driver Analysis
    • 3.2.1.1 Rising number of preterm and low-weight births
    • 3.2.1.2 Growing government and NGO initiatives
    • 3.2.1.3 Rising technological advancements
      • 3.2.1.4.1 Case Study: Innovation and benefits of the Kalstein infant phototherapy incubator
  • 3.2.2 Market Restraint Analysis
    • 3.2.2.1 Stringent regulatory framework
  • 3.2.3 Market Opportunities
    • 3.2.3.1 Growing shift toward home-based infant care
  • 3.2.4 Market Challenges Analysis
    • 3.2.4.1 Infrastructure constraints in developing countries
• 3.3 Industry Analysis Tools
  • 3.3.1 Porter's Five Forces Analysis
  • 3.3.2 PESTLE Analysis

Chapter 4. Infant Incubators and Warmers Market: Type Estimates & Trend Analysis

• 4.1 Infant Incubators and Warmers Market: Type Segment Dashboard
• 4.2 Type Movement & Market Share Analysis, 2025 & 2033
• 4.3 Global Infant Incubators & Warmers Market Size Estimates & Forecast, by Type
• 4.4 Global Infant Incubators & Warmers Market Volume Estimates & Forecast, by Type
• 4.5 Infant Incubators and Warmers Market Size & Forecast and Forecasts, By Device Type (USD Million)
  • 4.5.1 Infant Warmers
    • 4.5.1.1 Infant Warmers Market Price Bands, 2021 - 2033 (USD Million)
    • 4.5.1.2 Infant Warmers Market Price Bands, 2021 - 2033 (Unit Volume)
  • 4.5.2 Incubators
    • 4.5.2.1 Incubators Market Price Bands, 2021 - 2033 (USD Million)
    • 4.5.2.2 Incubators Market Price Bands, 2021 - 2033 (Unit Volume)
  • 4.5.3 Convertible Warmers & Incubators
    • 4.5.3.1 Convertible Warmers & Incubators Market Price Bands, 2021 - 2033 (USD Million)
    • 4.5.3.2 Convertible Warmers & Incubators Market Price Bands, 2021 - 2033 (Unit Volume)
  • 4.5.4 Infant Warmers
    • 4.5.4.1 Infant warmers market, 2021 - 2033 (USD Million)
    • 4.5.4.2 Infant warmers market, 2021 - 2033 (Unit Volume)
    • 4.5.4.3 Premium
      • 4.5.4.5.1 Premium infant warmers market, 2021 - 2033 (USD Million)
      • 4.5.4.5.2 Premium infant warmers market, 2021 - 2033 (Unit Volume)
    • 4.5.4.4 Performance
      • 4.5.4.4.1 Performance infant warmers market, 2021 - 2033 (USD Million)
      • 4.5.4.4.2 Performance infant warmers market, 2021 - 2033 (Unit Volume)
    • 4.5.4.5 Value
      • 4.5.4.5.1 Value infant warmers market, 2021 - 2033 (USD Million)
      • 4.5.4.5.2 Value infant warmers market, 2021 - 2033 (Unit Volume)
  • 4.5.5 Incubators
    • 4.5.5.1 Incubators market, 2021 - 2033 (USD Million)
    • 4.5.5.2 Incubators market, 2021 - 2033 (Unit Volume)
    • 4.5.5.3 Premium
      • 4.5.5.3.1 Premium incubators market, 2021 - 2033 (USD Million)
      • 4.5.5.3.2 Premium incubators market, 2021 - 2033 (Unit Volume)
    • 4.5.5.4 Performance
      • 4.5.5.4.1 Performance incubators market, 2021 - 2033 (USD Million)
      • 4.5.5.4.2 Performance incubators market, 2021 - 2033 (Unit Volume)
    • 4.5.5.4 Value
      • 4.5.5.4.1 Value incubators market, 2021 - 2033 (USD Million)
      • 4.5.5.4.2 Value incubators market, 2021 - 2033 (Unit Volume)
  • 4.5.6 Convertible Warmers & Incubators
    • 4.5.6.1 Convertible warmers & incubators market, 2021 - 2033 (USD Million)
    • 4.5.6.2 Convertible warmers & incubators market, 2021 - 2033 (Unit Volume)
    • 4.5.6.3 Premium
      • 4.5.6.3.1 Premium convertible warmers & incubators market, 2021 - 2033 (USD Million)
      • 4.5.6.3.2 Premium convertible warmers & incubators market, 2021 - 2033 (Unit Volume)
    • 4.5.6.4 Performance
      • 4.5.6.4.1 Performance convertible warmers & incubators market, 2021 - 2033 (USD Million)
      • 4.5.6.4.2 Performance convertible warmers & incubators market, 2021 - 2033 (Unit Volume)
    • 4.5.6.5 Value
      • 4.5.6.5.1 Value convertible warmers & incubators market, 2021 - 2033 (USD Million)
      • 4.5.6.5.2 Value convertible warmers & incubators market, 2021 - 2033 (Unit Volume)

Chapter 5. Infant Incubators and Warmers Market: Regional Estimates & Trend Analysis

• 5.1. Regional Market Share Analysis, 2025 & 2033
• 5.2. Regional Market Dashboard
• 5.3. Global Regional Market Snapshot
• 5.4. North America
  • 5.4.1. U.S.
    • 5.4.1.1. Key country dynamics
    • 5.4.1.2. Regulatory framework
    • 5.4.1.3. Competitive scenario
    • 5.4.1.4. U.S. market estimates and forecasts 2021 to 2033 (USD Million)
    • 5.4.1.5. U.S. market estimates and forecasts 2021 to 2033 (Unit Volume)
  • 5.4.2. Canada
    • 5.4.2.1. Key country dynamics
    • 5.4.2.2. Regulatory framework
    • 5.4.2.3. Competitive scenario
    • 5.4.2.4. Canada market estimates and forecasts 2021 to 2033 (USD Million)
    • 5.4.2.5. Canada market estimates and forecasts 2021 to 2033 (Unit Volume)
  • 5.4.3. Mexico
    • 5.4.3.1. Key country dynamics
    • 5.4.3.2. Regulatory framework
    • 5.4.3.3. Competitive scenario
    • 5.4.3.4. Mexico market estimates and forecasts 2021 to 2033 (USD Million)
    • 5.4.3.5. Mexico market estimates and forecasts 2021 to 2033 (Unit Volume)
• 5.5. Europe
  • 5.5.1. UK
    • 5.5.1.1. Key country dynamics
    • 5.5.1.2. Regulatory framework
    • 5.5.1.3. Competitive scenario
    • 5.5.1.4. UK market estimates and forecasts 2021 to 2033 (USD Million)
    • 5.5.1.5. UK market estimates and forecasts 2021 to 2033 (Unit Volume)
  • 5.5.2. Germany
    • 5.5.2.1. Key country dynamics
    • 5.5.2.2. Regulatory framework
    • 5.5.2.3. Competitive scenario
    • 5.5.2.4. Germany market estimates and forecasts 2021 to 2033 (USD Million)
    • 5.5.2.5. Germany market estimates and forecasts 2021 to 2033 (Unit Volume)
  • 5.5.3. France
    • 5.5.3.1. Key country dynamics
    • 5.5.3.2. Regulatory framework
    • 5.5.3.3. Competitive scenario
    • 5.5.3.4. France market estimates and forecasts 2021 to 2033 (USD Million)
    • 5.5.3.5. France market estimates and forecasts 2021 to 2033 (Unit Volume)
  • 5.5.4. Italy
    • 5.5.4.1. Key country dynamics
    • 5.5.4.2. Regulatory framework
    • 5.5.4.5. Competitive scenario
    • 5.5.4.4. Italy market estimates and forecasts 2021 to 2033 (USD Million)
    • 5.5.4.5. Italy market estimates and forecasts 2021 to 2033 (Unit Volume)
  • 5.5.5. Spain
    • 5.5.5.1. Key country dynamics
    • 5.5.5.2. Regulatory framework
    • 5.5.5.3. Competitive scenario
    • 5.5.5.4. Spain market estimates and forecasts 2021 to 2033 (USD Million)
    • 5.5.5.5. Spain market estimates and forecasts 2021 to 2033 (Unit Volume)
  • 5.5.6. Norway
    • 5.5.6.1. Key country dynamics
    • 5.5.6.2. Regulatory framework
    • 5.5.6.3. Competitive scenario
    • 5.5.6.4. Norway market estimates and forecasts 2021 to 2033 (USD Million)
    • 5.5.6.5. Norway market estimates and forecasts 2021 to 2033 (Unit Volume)
  • 5.5.7. Sweden
    • 5.5.7.1. Key country dynamics
    • 5.5.7.2. Regulatory framework
    • 5.5.7.3. Competitive scenario
    • 5.5.7.4. Sweden market estimates and forecasts 2021 to 2033 (USD Million)
    • 5.5.7.5. Sweden market estimates and forecasts 2021 to 2033 (Unit Volume)
  • 5.5.8. Denmark
    • 5.5.8.1. Key country dynamics
    • 5.5.8.2. Regulatory framework
    • 5.5.8.3. Competitive scenario
    • 5.5.8.4. Denmark market estimates and forecasts 2021 to 2033 (USD Million)
    • 5.5.8.5. Denmark market estimates and forecasts 2021 to 2033 (Unit Volume)
• 5.6. Asia Pacific
  • 5.6.1. Japan
    • 5.6.1.1. Key country dynamics
    • 5.6.1.2. Regulatory framework
    • 5.6.1.3. Competitive scenario
    • 5.6.1.4. Japan market estimates and forecasts 2021 to 2033 (USD Million)
    • 5.6.1.5. Japan market estimates and forecasts 2021 to 2033 (Unit Volume)
  • 5.6.2. China
    • 5.6.2.1. Key country dynamics
    • 5.6.2.2. Regulatory framework
    • 5.6.2.3. Competitive scenario
    • 5.6.2.4. China market estimates and forecasts 2021 to 2033 (USD Million)
    • 5.6.2.5. China market estimates and forecasts 2021 to 2033 (Unit Volume)
  • 5.6.3. India
    • 5.6.3.1. Key country dynamics
    • 5.6.3.2. Regulatory framework
    • 5.6.3.3. Competitive scenario
    • 5.6.3.4. India market estimates and forecasts 2021 to 2033 (USD Million)
    • 5.6.3.5. India market estimates and forecasts 2021 to 2033 (Unit Volume)
  • 5.6.4. Australia
    • 5.6.4.1. Key country dynamics
    • 5.6.4.2. Regulatory framework
    • 5.6.4.5. Competitive scenario
    • 5.6.4.4. Australia market estimates and forecasts 2021 to 2033 (USD Million)
    • 5.6.4.5. Australia market estimates and forecasts 2021 to 2033 (Unit Volume)
  • 5.6.5. South Korea
    • 5.6.5.1. Key country dynamics
    • 5.6.5.2. Regulatory framework
    • 5.6.5.3. Competitive scenario
    • 5.6.5.4. South Korea market estimates and forecasts 2021 to 2033 (USD Million)
    • 5.6.5.5. South Korea market estimates and forecasts 2021 to 2033 (Unit Volume)
  • 5.6.6. Thailand
    • 5.6.6.1. Key country dynamics
    • 5.6.6.2. Regulatory framework
    • 5.6.6.3. Competitive scenario
    • 5.6.6.4. Thailand market estimates and forecasts 2021 to 2033 (USD Million)
    • 5.6.6.5. Thailand market estimates and forecasts 2021 to 2033 (Unit Volume)
• 5.7. Latin America
  • 5.7.1. Brazil
    • 5.7.1.1. Key country dynamics
    • 5.7.1.2. Regulatory framework
    • 5.7.1.3. Competitive scenario
    • 5.7.1.4. Brazil market estimates and forecasts 2021 to 2033 (USD Million)
    • 5.7.1.5. Brazil market estimates and forecasts 2021 to 2033 (Unit Volume)
  • 5.7.2. Argentina
    • 5.7.2.1. Key country dynamics
    • 5.7.2.2. Regulatory framework
    • 5.7.2.3. Competitive scenario
    • 5.7.2.4. Argentina market estimates and forecasts 2021 to 2033 (USD Million)
    • 5.7.2.5. Argentina market estimates and forecasts 2021 to 2033 (Unit Volume)
• 5.8. MEA
  • 5.8.1. South Africa
    • 5.8.1.1. Key country dynamics
    • 5.8.1.2. Regulatory framework
    • 5.8.1.3. Competitive scenario
    • 5.8.1.4. South Africa market estimates and forecasts 2021 to 2033 (USD Million)
    • 5.8.1.5. South Africa market estimates and forecasts 2021 to 2033 (Unit Volume)
  • 5.8.2. Saudi Arabia
    • 5.8.2.1. Key country dynamics
    • 5.8.2.2. Regulatory framework
    • 5.8.2.3. Competitive scenario
    • 5.8.2.4. Saudi Arabia market estimates and forecasts 2021 to 2033 (USD Million)
    • 5.8.2.5. Saudi Arabia market estimates and forecasts 2021 to 2033 (Unit Volume)
  • 5.8.3. UAE
    • 5.8.3.1. Key country dynamics
    • 5.8.3.2. Regulatory framework
    • 5.8.3.3. Competitive scenario
    • 5.8.3.4. UAE market estimates and forecasts 2021 to 2033 (USD Million)
    • 5.8.3.5. UAE market estimates and forecasts 2021 to 2033 (Unit Volume)
  • 5.8.4. Kuwait
    • 5.8.4.1. Key country dynamics
    • 5.8.4.2. Regulatory framework
    • 5.8.4.5. Competitive scenario
    • 5.8.4.4. Kuwait market estimates and forecasts 2021 to 2033 (USD Million)
    • 5.8.4.5. Kuwait market estimates and forecasts 2021 to 2033 (Unit Volume)

Chapter 6. Competitive Landscape

• 6.1. Recent Developments & Impact Analysis, By Key Market Participants
• 6.2. Company/Competition Categorization
• 6.3. Estimated company market share analysis, 2025
• 6.4. List of Companies
  • 6.4.1. Atom Medical USA
    • 6.4.1.1. Company overview
    • 6.4.1.2. Financial performance
    • 6.4.1.3. Product benchmarking
    • 6.4.1.4. Strategic initiatives
  • 6.4.2. Dragerwerk AG & Co. KGaA
    • 6.4.2.1. Company overview
    • 6.4.2.2. Financial performance
    • 6.4.2.3. Product benchmarking
    • 6.4.2.4. Strategic initiatives
  • 6.4.5. GE HealthCare
    • 6.4.5.1. Company overview
    • 6.4.5.2. Financial performance
    • 6.4.5.3. Product benchmarking
    • 6.4.5.4. Strategic initiatives
  • 6.4.4. nice Neotech Medical Systems Pvt. Ltd.
    • 6.4.4.1. Company overview
    • 6.4.4.2. Financial performance
    • 6.4.4.5. Product benchmarking
    • 6.4.4.4. Strategic initiatives
  • 6.4.5. LEEX LLC
    • 6.4.5.1. Company overview
    • 6.4.5.2. Financial performance
    • 6.4.5.3. Product benchmarking
    • 6.4.5.4. Strategic initiatives
  • 6.4.6. International Biomedical Ltd.
    • 6.4.6.1. Company overview
    • 6.4.6.2. Financial performance
    • 6.4.6.3. Product benchmarking
    • 6.4.6.4. Strategic initiatives
  • 6.4.7. mOm Incubators Ltd
    • 6.4.7.1. Company overview
    • 6.4.7.2. Financial performance
    • 6.4.7.3. Product benchmarking
    • 6.4.7.4. Strategic initiatives
  • 6.4.8. Zimed Healthcare Inc
    • 6.4.8.1. Company overview
    • 6.4.8.2. Financial performance
    • 6.4.8.3. Product benchmarking
    • 6.4.8.4. Strategic initiatives
  • 6.4.9. DIAMEDICAL USA EQUIPMENT LLC
    • 6.4.9.1. Company overview
    • 6.4.9.2. Financial performance
    • 6.4.9.3. Product benchmarking
    • 6.4.9.4. Strategic initiatives
  • 6.4.10. Mediprema's Group
    • 6.4.10.1. Company overview
    • 6.4.10.2. Financial performance
    • 6.4.10.3. Product benchmarking
    • 6.4.10.4. Strategic initiatives
  • 6.4.11. Apothecaries Sundries Mfg. Pvt. Ltd. (ASCO)
    • 6.4.11.1. Company overview
    • 6.4.11.2. Financial performance
    • 6.4.11.3. Product benchmarking
    • 6.4.11.4. Strategic initiatives
  • 6.4.12. BioAge Labs
    • 6.4.12.1. Company overview
    • 6.4.12.2. Financial performance
    • 6.4.12.3. Product benchmarking
    • 6.4.12.4. Strategic initiatives